Navigation Links
Simmons Hanly Conroy Shareholder Trent Miracle Appointed Co-Lead in Federal Testosterone Replacement Therapy Litigation
Date:8/5/2014

CHICAGO, Aug. 5, 2014 /PRNewswire/ -- A federal judge has appointed Simmons Hanly Conroy Shareholder Trent Miracle as co-lead counsel in the national multidistrict litigation pending against the manufacturers of testosterone therapy replacement treatments.

In an order entered July 31, the Honorable Matthew F. Kennelly, of the U.S. District Court for the Northern District of Illinois, appointed Miracle and attorneys Ronald E. Johnson Jr. and Christopher A. Seeger as co-lead counsel for the plaintiffs in the testosterone replacement therapy products liability litigation. Miracle and his co-leads will manage the federal litigation and oversee 29 other attorneys representing men who were seriously injured while taking testosterone replacement therapies.

"This is an important litigation that could impact thousands of men throughout the country," Miracle said. "Judge Kennelly's appointments include some of the nation's top trial attorneys, and I'm looking forward to working with them as we fight for the rights of those unnecessarily harmed while receiving testosterone replacement therapy."

Earlier this year, the U.S. Food & Drug Administration issued a safety announcement about the increased risks associated with low testosterone treatment therapies. Based on new research which found men taking testosterone treatments had a greater chance of suffering a heart attack or stroke, the FDA launched its own investigation of testosterone replacement therapy.

In February 2014, Simmons Hanly Conroy, led by
'/>"/>

SOURCE Simmons Hanly Conroy
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positron Appoints Charles Conroy As Chief Operating Officer
2. TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card
3. Sinovac Schedules 2014 Annual Meeting of Shareholders
4. ImmunoCellular Therapeutics Issues Shareholder Letter Providing Update on ICT-107 Program in Newly Diagnosed Glioblastoma
5. Medbox Updates Shareholders on Dividend Issuance
6. Mindray Announced Shareholder Resolutions Post 2013 Annual General Meeting
7. Simcere Pharmaceutical Group Announces Shareholders Approval of the Merger Agreement
8. Pro-Dex, Inc. Announces Plans For Rights Offering To Shareholders
9. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Solta Medical, Inc. - SLTM
10. NW Bio Responds To Shareholder Inquiries Following Immune Therapy Sectors Recent Market Decline
11. Concord Medical Announces the Closing of Acquisition of Its Shares by CEO and COO from Other Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Varian Medical Systems UK Ltd announced today it ... and service two new national NHS proton therapy centers in ... proton therapy system. Earlier this year, Varian announced that ... NHS centers to be constructed in London ... book the equipment portion of the order in its fiscal ...
(Date:7/27/2015)... 27, 2015   Iagnosis , the creator ... in online dermatology solutions, announced today its 2015 ... company has contractual relationships with dermatologists in 30 ... Dermatologists and Extenders Since December 2014, ... number of providers delivering care through the platform, ...
(Date:7/27/2015)... , July 27, 2015  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, today announced ... (CTA) with Heath Canada to conduct ... d-Methadone (dextromethadone, REL-1017), its novel, N-methyl-D-aspartate (NMDA) receptor ... pain. "We are very encouraged by ...
Breaking Medicine Technology:Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 2Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 4Iagnosis Reports Significant Growth YTD 2015 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 3
... 16 Trubion Pharmaceuticals, Inc. (Nasdaq: ... data regarding its SCORPION(TM) multispecific therapeutic technology at ... of Cancer Research (AACR) in Denver, April 18-22, ... data demonstrating the selectivity and high potency of ...
... Agonist to Advance for Treatment of AllergySAN DIEGO , ... company focused on the development of novel Toll-Like Receptor ... and inflammatory diseases, announced today that it has initiated ... intranasal TLR8 agonist for the treatment of allergic rhinitis. ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
(Date:7/28/2015)... ... July 28, 2015 , ... Want to improve your ... or in your easy chair? Luckily, there are plenty of back-friendly cardio exercises that ... orthopedic spine surgeon at Atlantic Spine Center . , It’s simply untrue ...
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, ... offer behavioral health counseling for persons who are obese and those who are overweight ... clear. , That mandate will affect any commercial health plan with a program year ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of ... the NAPW VIP Woman of the Year Circle. She is recognized with this prestigious ... Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional women. , ...
(Date:7/27/2015)... ... , ... The heroin epidemic is affecting the Charlotte in North Carolina equally ... rate for heroin usage has continued to climb around the country in part because ... alternative for those with an addiction to prescription opiate medications. According to WCNC, the ...
(Date:7/27/2015)... ... 27, 2015 , ... Looking to brush up on all the things you ... New Jersey has enhanced its Dental webpage with new materials, including user-friendly, educational videos, ... “Horizon is committed to offering our 3.8 million members tools and resources to help ...
Breaking Medicine News(10 mins):Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2
... of studies,School-based sexual abuse prevention programs can teach children ... ,However, the programs have a downside: they ... the review cautions. ,,It was a concern that ... review, but we were pleased that there was an ...
... every time you feel a cold starting isnt such a good ... will most probably end up getting the sniffles . ... over several decades and including more than 11,000 people who took ... ,The review, according to the researchers at the Australian National ...
... of pregnancy rumours once again when she was pictured with ... York premiere of John Travolta starrer Hairspray dressed in a ... reports the Daily Mail. ,Holmes sparked off rumours ... child when she was spotted with bump while visiting new ...
... Sreemathi Wednesday said the government was not averse to inviting ... of a mosquito borne fever in the state that has ... different expert teams have arrived in the state since the ... reports, which have confirmed the fever as chikunguniya and nothing ...
... reserved seats for students suffering from AIDS and cancer in ... reserved one seat for each of the fifty-six courses that ... cancer. ,However, the university feels that one seat ... being, since it do not expects many patients queuing up ...
... that set out to assess the effectiveness and tolerability ... methods of contraception found that they were all good ... implant was found to be any more or less ... ,,The most common side effect with all the implants ...
Cached Medicine News:Health News:School-based Sexual Abuse Prevention Programs 2Health News:School-based Sexual Abuse Prevention Programs 3
This design features a solid red iris....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
Medicine Products: